000 01519 a2200505 4500
005 20250512220558.0
264 0 _c19850226
008 198502s 0 0 eng d
022 _a0162-0886
024 7 _a10.1093/clinids/6.supplement_4.s821
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNightingale, C H
245 0 0 _aTissue penetration and half-life of cefonicid.
_h[electronic resource]
260 _bReviews of infectious diseases
_c
300 _aS821-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCardiac Surgical Procedures
650 0 4 _aCefamandole
_xanalogs & derivatives
650 0 4 _aCefazolin
_xmetabolism
650 0 4 _aCefonicid
650 0 4 _aCefoxitin
_xmetabolism
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHip Prosthesis
650 0 4 _aHumans
650 0 4 _aHysterectomy
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPremedication
650 0 4 _aTime Factors
650 0 4 _aTissue Distribution
700 1 _aQuintiliani, R
700 1 _aDudley, M N
700 1 _aGough, P
700 1 _aHickingbotham, M
700 1 _aJordan, N S
700 1 _aRose, D
700 1 _aToscani, M
773 0 _tReviews of infectious diseases
_gvol. 6 Suppl 4
_gp. S821-8
856 4 0 _uhttps://doi.org/10.1093/clinids/6.supplement_4.s821
_zAvailable from publisher's website
999 _c6522804
_d6522804